Condition: COPD (Chronic Obstructive Pulmonary Disease) · Lung Cancer (Diagnosis) · Lung Neoplasm Malignant · Sponsor: Ditte Krag-Hansen
Identifying and treating COPD in patients undergoing lung cancer evaluation is crucial. Early intervention could lead to better management of both diseases, improving health status, reducing healthcare costs, and potentially increasing survival rates. This study aims to assess the impact of early diagnosis and optimal treatment of COPD on clinical outcomes in patients under evaluation for lung cancer. The study will combine information through an open-label RCT at the Lung Cancer Investigation Unit at Lillebaelt Hospital Vejle. The findings could inform clinical practice by emphasizing the importance of integrated care approaches for patients with coexisting COPD and lung cancer, ultimately leading to better health outcomes.
This description comes directly from the study's public registry record.
Ditte Krag-Hansen, MD, PhD student · +45 7940 5720 · ditte.krag-hansen@rsyd.dk
Morten Hornemann Borg, MD, PhD, Chief consultant · morten.hornemann.borg@rsyd.dk
Always discuss trial participation with your own doctor first.
| Lung Cancer Investigation Unit, Lillebaelt Hospital Vejle | Vejle, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07543601